Respiratory Inhalers Market, By Type (Manually Operated and Digitally Operated), By Product (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Arterial Hypertension, Other), By End User (Hospitals & Clinics, Respiratory Care Center, Academic and Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024

Code : CMI227

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Respiratory Inhalers Market Regional Insights

To learn more about this report, request sample copy

North America dominates the respiratory inhalers market with an estimated market share of 41.2% in 2024 The presence of leading global pharmaceutical companies such as GSK, Teva, Chiesi, and Sunovion provides the region with easy access to most innovative portfolio of inhalers. Majority of the phase 3 clinical trials for new inhalers are conducted across the U.S. and Canada which ensures early introduction of novel products in the region. Furthermore, North America has a highly developed healthcare infrastructure and favorable reimbursement policies supporting increased adoption of respiratory inhalers.

The region is also a hub for generic inhalers manufacturing. Several domestic manufacturers focus on developing low-cost generic versions, making respiratory therapy more affordable. This has increased the reach of inhalers to a broader patient base suffering from respiratory disorders like asthma and COPD. Growing geriatric population susceptible to chronic respiratory conditions in the U.S. and Canada can boost demand. High awareness levels among healthcare providers and patients regarding inhalers as primary mode of treatment administration further strengthens North America's position as the most profitable market.

Asia Pacific region is emerging as the fastest growing market for respiratory inhalers. Countries like China, India, and Japan have a massive patient pool suffering from both communicable and non-communicable respiratory diseases. This large prevalence rate along with the improving access to healthcare present significant growth opportunities. Manufacturers are focusing their expansion strategies in Asia Pacific by establishing local manufacturing plants and distribution networks.